Research grant holder

In 2018 he obtained a master's degree in Cellular and Molecular Biology and in 2024 he finished the PhD course in the Area of Drugs and Innovative Treatments at the University of Florence with a thesis focused on the study of the acute and chronic effects of cannabinoids in models in vitro neurodegenerative diseases such as ischemia and epilepsy. He currently holds a research grant focused on the role of bioactive sphingolipids in neurodegeneration models at the Department of Health Sciences (DSS) of the University of Florence. His research centers on the study of the cellular and molecular mechanisms underlying neurodegenerative diseases, such as cerebral ischemia and epilepsy, and in the search for new possible selective drug treatments. His preclinical studies make use of in vitro models of blood-brain barrier cells, pure neurons, glia and organotypic cultures as well as in vivo models of cerebral ischemia and neonatal hypoxic-ischemic encephalopathy.